Sanofi to enhance synergy with China’s pharma market

Strong operations: The Sanofi headquarters in Paris. Sanofi has built three manufacturing sites in China – in Beijing, Hangzhou in Zhejiang province, and Shenzhen in Guangdong province. — Bloomberg

BEIJING: French pharmaceutical company Sanofi will accelerate the modernisation of its manufacturing sites and research network in China to better integrate these into its global industrial system, a senior company executive says.

The company will also reform its medical practices and share revolutionary new drug research and development and manufacturing technologies, innovative therapies and new drugs with China, to contribute more to the development of China’s pharmaceutical industry through cross-border integration, Wayne Shi, president of Sanofi Greater China, told China Daily.